Search Results
Exclusive Financial Advisor to CURO Group Holdings Corp.
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to CURO Group Holdings Corp. during the company’s $2,102,000,000 Chapter 11 Reorganization
Exclusive Financial Advisor to Cottonwood Financial in a 363 Bankruptcy Sale
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to Cottonwood Financial on its Acquisition by CNG Holdings via a Section 363 Bankruptcy Sale
Exclusive Financial Advisor to BastionZero
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to BastionZero, Inc. on its acquisition by Cloudflare, Inc. (NYSE: NET)
Exclusive Financial Advisor to AlTi Global, Inc.
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to AlTi Global, Inc. on its strategic investment of up to $450MM from Allianz X and Constellation Wealth Capital
Exclusive Financial Advisor to 3 of Rhode Island's Leading Gastroenterology Practices On Sale to GI Alliance
Oppenheimer & Co. Inc. served as Exclusive Financial Advisor for University Gastroenterology, Gastroenterology Associates, and Gastrointestinal Medicine Associates
Exclusive Financial Adviser to CEWE Stiftung & Co. KGaA on the sale of futalis GmbH
Oppenheimer’s European Investment Banking Team is pleased to have acted as Exclusive Financial Adviser to CEWE Stiftung & Co. KGaA on the sale of futalis GmbH to its Management
Constructing Revenue Solutions: A Survey of State and Local Governments
Constructing Revenue Solutions
Co-Manager on Dyne Therapeutics' Follow-On Offering
Oppenheimer & Co. Inc. acted as Co-Manager on Dyne Therapeutics’ $345MM Follow-On Offering
Capital Markets Advisor for Pinstripes, Inc.
Oppenheimer & Co. Inc. acted as Capital Markets Advisor for Pinstripes, Inc. on its $438,000,000 business combination with Banyan Acquisition Corp. (NYSE: BYN)
Active Joint Bookrunner for Evolent Health, Inc.
Oppenheimer & Co. Inc. acted as Active Joint Bookrunner for Evolent Health, Inc. on its $402.5 Million Convertible Senior Note Offering